Life Science News

RSS

New prime assembly method enables long and precise DNA insertions

Genomic editing holds great potential yet continues to have its limitations. Most current methods either rely on untargeted gene delivery or short DNA edits that need to be individualized to each patient.

16 Sep 2026

Study establishes foundational landscape of tumor evolution in bladder cancer

A new study published in Nature has established the foundational landscape of tumor evolution in bladder cancer and differences in the cancer subtypes, which could point toward better diagnosis and treatment of the disease.

16 Sep 2026

Norwegian scientists harvest super donor cells to fight diverse diseases

Cells from nine "super donors" are being collected in Oslo. The aim is for these to be used to repair or replace damaged cells, tissue and organs in people suffering from conditions ranging from heart attacks to Parkinson's disease.

16 Sep 2026

Peer-reviewed study shows six times lower blood damage in Realheart® TAH than market-leading device in vitro

Scandinavian Real Heart AB (publ) announces today that a study sponsored by the company has been published in the peer-reviewed journal Nature Scientific Reports, showing that the Realheart® TAH causes about six times less blood damage (hemolysis) than the only FDA-approved artificial heart device currently in wide clinical use.

16 Sep 2026

ACROBiosystems deepens its France presence with a dedicated hub at The HIVE Innovation Center, embedding into the Campus Grand Parc ecosystem

Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life sciences, situated on the Campus Grand Parc in Villejuif.

From ACROBiosystems 16 Sep 2026

MGI launches VisiOmics in Europe and unveils AI-enabled pathology portfolio at ECP 2026

MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life science, today announced the European launch of VisiOmics (PMIF-20RS), a fully automated multiplex immunofluorescence (mIF) staining and imaging system, at the 38th European Congress of Pathology (ECP 2026), held in Stockholm from 12 to 16 September 2026.

From MGI 16 Sep 2026

New 3D structure reveals how cancer-linked BRD4 protein binds to chromosomes

A new 3D-structure of a cancer-linked protein bound to its cellular partner reveals details of how the protein binds to chromosomes and could offer insights for future disease treatments.

15 Sep 2026

Genetic discovery offers clues for repairing damaged neural connections

A new discovery by neuroscientists at Brown University's Carney Institute for Brain Science challenges long-held beliefs in neurobiology about how neurons extend axons to reach their targets.

15 Sep 2026

Study identifies DNA loops as essential for tissue regeneration

After an injury, DNA not only alters its activity but also the way it is organized spatially within the cell nucleus.

15 Sep 2026

Advanced AI cell models redefine modern cell biology research

Researchers at Stanford Medicine have developed two new artificial intelligence models of the biological cell.

15 Sep 2026

Study uncovers mechanism for reading extra-long neuronal genes

Neurons in humans and other mammals express many exceptionally long genes, ranging from more than 100 kb to over 2 Mb, that are important for forming synapses and neural circuits.

15 Sep 2026

Aston University partners with Labskin to grow more realistic laboratory-grown human skin

Aston University has joined forces with Yorkshire-based biotechnology company Labskin to develop more realistic laboratory-grown human skin that includes immune cells.

15 Sep 2026

Insilico Medicine launches AI initiative to develop longevity vaccines

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced Longevity Vaccines, a research initiative developing treatments that direct a patient's own immune cells to eliminate the earliest cellular drivers of age-related disease.

15 Sep 2026

HORIBA air quality monitor AP-380 series achieves key UK MCERTS certification

With MCERTS certification, HORIBA's AP-380 Series ensures dependable trace gas measurement, crucial for effective air pollution monitoring across industries.

From HORIBA Scientific UK 15 Sep 2026

Malvern Panalytical launches Zetasizer Core – an industry first in biologics plate-based stability screening

Malvern Panalytical's Zetasizer Core integrates DLS, SLS, and DSF in one platform, streamlining biologics discovery with unmatched efficiency and precision.

From Malvern Panalytical 15 Sep 2026

Optimizing respiratory virus research workflows with VACUBOY

UTS researchers utilize the VACUBOY and VACUSAFE systems to enhance respiratory health studies, streamlining cell culture workflows and improving productivity.

15 Sep 2026

Orexo announces FDA acceptance of Investigational New Drug (IND) application for OX640 for the treatment of anaphylaxis

Orexo AB (publ.) today announces that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for OX640, a nasally administered powder formulation of epinephrine intended for the emergency treatment of anaphylaxis.

15 Sep 2026